~~<i id='A9696AD531'><strike id='A9696AD531'><tt id='A9696AD531'><pre id='A9696AD531'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：comprehensive 2025-10-01 23:59:15 - browse：511

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Researchers test human milk's ability to repair gut microbiome

explore

entertainment

focus

knowledge

leisure time

EricLanderresignedasPresidentBiden’sscienceadviser,afteraWhiteHouseinvestigationfound“credibleeviden

WSS

Overprescribed: High cost isn't America's only drug problem

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

PrEP can help anyone prevent HIV. Why do so few people take it?

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

hotspot

fashion

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Severe heat forecast: Where scorching temperatures will persist over the next week

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Virginia high school admissions case could be legal follow

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

State Dept. review finds Biden bears some blame for Afghanistan failures

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mass General Brigham physicians react to latest merger step

entertainment

Malaysia cuts short music fest after British band slams anti

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Doctors have an ethical obligation to be advocates

U.K. decision on ALS drug has neurologists, advocates up in arms

First Opinion on colorectal cancer screening: letter and response

Researchers test human milk's ability to repair gut microbiome

focus

focus

knowledge

leisure time